Eurofins DiscoverX offers two target engagement assay platforms, InCELL Pulse and InCELL Hunter. The InCELL Hunter platform offers researchers cell lines, ready-to-use kits and profiling services for specific targets. The InCELL Pulse platform offers researchers ready-to-use kits for specific targets and a do-it-yourself, starter kit perfect for creating your own compound-target engagement assay.
View the available stable cell lines, assay-ready kits, starter kit, and detection reagents.
Assay Ready Kits
for creating your own cell-based target engagement assays
for 25 under-studied and well-studied kinases available upon request
for creating your own InCELL Pulse cell-based target engagement assays. These include off-target kinases.
Custom Assay Development
InCELL Hunter and InCELL Pulse Platforms
Eurofins DiscoverX offers two InCELL target engagement assay platforms—InCELL Hunter and InCELL Pulse—both based on the industry validated Enzyme Fragment Complementation (EFC) technology
. Theses assays enable the determination of compound cell entry and measurement of compound engagement to an intracellular protein target in a native cellular environment. In addition, the InCELL Pulse platform is built on the principle of protein thermal stability, using which compound-target binding is detected.
To learn more about the differences of each assay platform, read our blog Comparison of InCELL Hunter vs InCELL Pulse for Analyzing Compound-Target Engagement
InCELL Hunter Stabilized Compound-Protein Complex Assay Format
The intracellular target protein in these assays is fused with a small enzyme donor fragment of β-galactosidase (β-gal) called enhanced ProLabel® (ePL). Upon addition of a compound that binds the target, protein levels are stabilized or altered in the cell, and this change can be monitored by measuring target protein abundance using chemiluminescent detection. The detection reagents include a chemiluminescent substrate added with a large enzyme acceptor (EA) fragment that naturally complements with the ePL tag on the target protein to create an active β-gal enzyme. The resulting active enzyme hydrolyzes the substrate to generate a chemiluminescent signal. The greater the signal corresponds to greater presence of compound-target engagement in the cell.
InCELL Hunter Destabilized Partner Protein Assay Format
In these assays, cell lines are engineered to co-express an untagged target protein and an interacting partner protein fused with ePL. In the absence of an inhibitor compound, the untagged target and ePL-tagged partner protein interact, resulting in stable steady-state levels of ePL-tagged partner protein. Addition of inhibitors that bind the target protein and disrupt the target-partner protein interaction results in ePL-tagged partner protein degradation. The abundance of ePL-tagged partner protein is measured by chemiluminescent detection similar to the format above. The greater the signal corresponds to less compound-target engagement in the cell.
InCELL Pulse Assay Principle
The InCELL Pulse compound-target engagement assays are based on a novel cellular application of the EFC technology incorporating compound binding detection based on protein thermal stability. Cells expressing a protein of interest fused to the ePL tag are treated with test compound and then subjected to elevated temperatures during a pulse denaturation step. Compound binding protects the target protein from thermal denaturation, which enhances complementation between EA and ePL and increases the chemiluminescent signal measured using the EFC-based detection system. In the absence of compound binding, the target protein forms denatured aggregates that poorly complement with EA, which results in a low chemiluminescent signal.
Measure and Rank Inhibitory Potency Against Your Intracellular Protein Target
Analyze a variety of intracellular protein targets such as kinases, hydrolases, methyltransferases, and bromodomains.
ABL1 Tyrosine Kinase InCELL Pulse Assay
ABL1 tyrosine kinase cellular target-engagement dose-response curves for type I, type II, and allosteric inhibitors using the InCELL Pulse assay with one pulse denaturation cycle at 48°C for 4 minutes. A. The type I and II inhibitors dasatinib and imatinib, respectively, show the correct rank-order potencies. The lipid kinase inhibitor PI103 was included as a negative control. B. The allosteric inhibitor GNF2, which targets the myristate binding site in the C-terminal kinase lobe, is detected using the ABL1 InCELL Pulse assay.
MTH1 Hydrolase InCELL Pulse Assay
MTH1 hydrolase cellular target-engagement dose-response curves for the diverse inhibitors TH588, S-crizotinib, and SCH 51344 show the correct rank order potencies using the InCELL Pulse assay with one pulse denaturation cycle at 48°C for 2.5 minutes. The lipid kinase inhibitor PI103 was included as a negative control.
BRD4(1) Bromodomain InCELL Hunter Assay
Bromodomains, such as BRD4(1), are epigenetic proteins that have no enzymatic activity and less number of assays available. BRD4(1) cellular target-engagement dose-response curves for the inhibitors JQ1(+), I-BET, and E12348 show the correct rank order potencies using the InCELL Hunter assay.
Identify Cell Permeable Compounds with the Best Cellular Potency
Confirm compound cell entry and target binding in the native cellular environment.
G9a Methyltransferase InCELL Hunter Assay
InCELL Hunter G9a methyltransferase target engagement assay identifies compounds with the best cellular potency. Published biochemical IC50
’s indicate compounds bind with defined affinities outside the cell. The InCELL Hunter assay shows compounds with similar biochemical IC50
do not have the same binding affinity to the target inside a cell. Results suggests the compound UNC0321 is not as cell permeable as UNC0638 or not as good at engaging the target in an intracellular environment. [Cellular IC50
reference: Nature Chemical Biology
. 2011; 7(8): 566-574.]